歴史のなかで日本が果たした役割

出版社： メディカルレビュー社
著者：
発行日： 2014-05-25
分野： 臨床医学：内科  >  膠原病/リウマチ
ISBN： 9784779212987
電子書籍版： 2014-05-25 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,100 円(税込)

購入する

目次

  • 歴史のなかで日本が果たした役割

    ―目次―

    I章　リウマチ治療の歴史
    　１．20世紀半ばのリウマチ治療の一面
    　２．リウマチ熱から関節リウマチへ

    II章　リウマチ学創成期の病理学研究
    　１．海外の病理学研究
    　２．日本の病理学研究
    　３．関節炎局所の病理学的変化

    III章　サリチル酸に始まった消炎鎮痛剤開発

    IV章　金製剤に始まった関節リウマチ治療薬開発
    　１．金製剤の開発

    V章　温泉治療

    VI章　リウマチ学のルネッサンス期（1950年頃）
    　１．自己抗体の発見
    　２．ステロイド薬の開発

    VII章　1950年頃の日本における薬物治療の実態

    VIII章　手術医療への途
    　１．滑膜切除術
    　２．調圧神経切除手術

    IX章　関節形成術
    　１．中間挿入膜使用からモールド（カップ）関節形成術へ
    　２．人工股関節置換手術の発展
    　３．人工膝関節手術の発展
    　４．人工肘関節手術の発展

    X章　1960年以後の滑膜切除術
    　１．欧米における滑膜切除術
    　２．日本で発展し続けた滑膜切除術

    XI章　病因・病態研究
    　１．滑膜細胞の電子顕微鏡学的病態解明
    　２．関節リウマチの発症誘因としての微生物説
    　３．関節リウマチの骨髄主病巣説

    XII章　疫学研究
    　１．環境要因（罹病率・有病率）の検討
    　２．遺伝要因の検討

    XIII章　日本で使われている関節リウマチ治療薬の開発研究
    　１．免疫調節薬
    　２．SH剤（sulfhydryl化合物）
    　３．その他
    　４．免疫抑制薬

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

引用文献

P.58 掲載の参考文献
1) Textbook of the rheumatic diseases (3rd ed.), WSC Copeman, E & SLivingstone ltd, Edinburgh and London, 1964
 
2) History of Rheumatology. ed by Smyth CJ, Freyberg RH, McEwen C. Atlanta, Georgia, Arthritis Foundation, 1985
 
3) Landmark Advances in Rheumatology. ed by MacCarty DJ. Publication of the American Rheumatism Association, Commemorating its 50th Anniversary, 1985
 
4) 清水源一郎編, リウマチ ; 新しい考え方と治療大阪, 永井書店, 132-169, 1955
 
5) 田中清介 : 日本におけるリウマチの学会の歴史と展望. 臨床リウマチ 18 : 1-12, 2006
 
6) Kahn MF, Beraneck L Daudin M (浅井克晏訳) : リウマチ 28 : 389-398, 1988
 
7) 伊藤久次 : (総説) リウマチのRehabilitationについてリウマチ 1 : 4-21, 1958
 
8) Bywaters EG : The relation between heart and joint disease including "rheumatoid heart disease" and chronic post rheumatic arthritis (type Jaccoud). Br Heart J 12 : 101-131, 1950
PubMed
9) Aschoff L : Zur Myocarditisfrage. Verh Disch Path Ges 7 : 46-53, 1904
 
10) Klinge F : Der Rheumatisms : pathologisch-anatomische und experimentell-pathologische Tatsachen und ihre Auswertung fur das arztliche Rheumaproblem. Ergebn Allg Pathol Pathol Anat 27 : 243-254, 1933
 
11) Klemperer P : The concept of collagen diseases. Am J Pathol 26 : 505-519, 1950
PubMed
12) Kellgren JH : Some concepts of rheumatic disease, Br Med J 1 : 1093-1098, 1952
 
13) 三木威勇治, 五百木雅孝, 高橋純, 川村次郎, 横関嘉伸, 御巫清允, 景山孝正, 植村孝秀, 高橋利雄, 児玉俊夫 : 慢性関節炎の分類とその臨床. 清水源一郎編, リウマチ ; 新しい考え方と治療, 大阪, 永井書店, 106-131, 1955
 
14) 七川歓次 : リウマチの治療 : 50年の歩み. 臨整外 44 : 1209-1217, 2009
 
15) 児玉俊夫, 高橋純, 川村次郎, 松本淳, 景山孝正, 植村孝秀 : 慢性関節炎の分類とその臨床. 整形外科 4 : 188-200, 1953
 
16) Bennett GA, Cobb S, Jacox R, et al : Proposed diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 7 : 121-124, 1956
PubMed
17) Ropes MW, Bennett GA, Cobb S, et al : 1958 revision of diagnostic criteria for rheumatoid arthritis, Bull Rheum Dis 9 : 175-176, 1958
PubMed
18) Arnett FC, Edworthy SM, Block DA, et al : The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 : 315-324, 1988
 
19) 大高裕一 : 永年にわたるフィブリノイド研究の回顧と, 今後の研究課題. リウマチ 30 : 77-80, 1990
 
20) Billings F : Chronic focal infections and their etiologic relation to arthritis and nephritis. Arch Intern Med 9 : 484-498, 1912
 
21) Sir Alfred Garrod : A Treatise on Gout and Rheumatic Gout (rheumatoid Arthritis), 1876
 
22) 七川歓次 : 日本リウマチ学会創設のころ. 日本リウマチ学会/日本リウマチ協会創立20周年記念座談会 ; 日本リウマチ学会誌号外 (1977年5月13日)
 
23) Okabayashi A, Chiuma E : Histogenesis of the Asghoff body. Pathology International 1 : 163-173, 1951
 
24) 岡林篤, 藤本輝夫, 山中博 : アショッフ体の組織発生 ; リウマチ像本態の探求. 清水源一郎編. リウマチ ; 新しい考え方と治療. 大阪, 永井書店, 41-59, 1955
 
25) 清水源一郎, 七川歓次 : 慢性多発関節リウマチの治療 ; 調圧神経切除の意義. 清水源一郎編, リウマチ ; 新しい考え方と治療. 大阪, 永井書店, 132-169, 1955
 
26) 鈴江懐 : リウマチの病理とくにリウマチ結節について. 清水源一郎編, リウマチ ; 新しい考え方と治療. 大阪, 永井書店, 60-77, 1955
 
27) 大高裕一 : リウマチの病理解剖. 清水源一郎編, リウマチ ; 新しい考え方と治療. 大阪, 永井書店, 1-40, 1955
 
28) MacLagan TJ : The treatment of acute rheumatism by salacin. Lancet 1 : 342-343, 383-384, 1876
 
29) Riess L : Nachtrag zur innerlichen Anwendung der Salicylsaure, insbesondere bei dem akuten Gelenkrheumatismus. Berl Klin Wochenschr 13 : 86-89, 1876
 
30) Stricker F : Uber die Resultate der Behandlung der Polytharthritis rheumatica mit Salicylsaure. Berl Klin Wochenschr 13 : 1, 15, 99, 1876
 
31) Boots RH, Miller CP : Astudy of neocinchophen in the treatment of rheumatic fever. JAMA 82 : 1028-1036, 1924
 
32) Vane JR : lnhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231 : 232-235, 1971
 
33) Shen TY, Windholz TB, Rosegay A et al Nonsteroidalanti-inflammatory agents. J Am Chem Soc 85 : 488-489, 1963
 
34) Slot G, Deville PM, Hill NG, et al : Treatment of arthritis and rheumatism with gold. Lancet 223 : 73-76, 1934
 
35) Lande K : Die gunstige Beeinflussung schleichender Dauerinfekte durch Solganal. Munch Med Wochenschr 74 : 1132-1134, 1927
 
36) Forestier J : L'aurotherapie dans les rhumatismes chroniques. Bull Mem Soc Med Hop Paris 53 : 323-327, 1929
 
37) Forestier J : Rheumatoid arthritis and its treatment by gold salts ; the results of si×years'experience, J Lab Clin Med 20 : 827-840, 1935
 
38) Forestier J : The treatment of rheumatoid arthritis with gold salts injections. Lancet 291 : 441-444, 1932
 
39) Smyth CJ, Freyberg RH, McEwen C : Progress in the management of rheumatic diseases, Chapter 11 in History of Rheumatology. 115-142, Arthritis Foundation, Atlanta, Georgia, 1985
 
40) Empire Rheumatism Council Subcommittee : Gold therapy in rheumatoid arthritis ; final report of a multicentre controlled trial. Ann Rheum Dis 20 : 315-334, 1961
 
41) Cooperating Clinics Committee of the American Rheumatism Association : Acontrolled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 16 : 353-358, 1973
 
42) Freyberg RH, Block WD, Fromer MF : A study of sulfur metabolism and the effect of sulfur administration in chronic arthritis, J Clin Invest 19 : 423-435, 1940
 
43) Dreyer I, Reed CI : The treatment of arthritis with massive doses of vitamin D. Arch Phys Ther 16 : 537-543, 1935
 
44) Page F : Treatment of lupus erythematosus with mepacrine. Lancet 2 : 755-758, 1951
PubMed
45) Mainland D, Sutcliffe Ml : Hydroxyl-chloroquine sulfate in rheumatoid arthritis, a si×month, double-blind trial. Bull Rheum Dis 13 : 287-290, 1962
 
46) 矢野良一 : わが国と欧米におけるリウマチのちがい. リウマチ 1 : 49-50, 1958
 
47) 杉山尚 : リウマチと温泉 ; 温泉はどうしてリウマチに効くか. リウマチ 17 : 147-150, 1977
 
48) 吉沢久嘉 : 温泉連浴の副腎皮質機能に及ぼす影響 第一部単純温泉連浴の軽症リウマチ患者副腎皮質機能に及ぼす影響. リウマチ 1 : 130-139, 1958
 
49) 吉沢久嘉 : 温泉連浴の副腎皮質機能に及ぼす影響 第二部浴湯反応時に於ける副腎皮質機能. リウマチ 2 : 112-117, 1959
 
50) 延永正 : 慢性関節リウマチのリハビリテーション. リウマチ 19 : 126-134, 1979
 
51) Waaler E : On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Path Microbiol Scand 17 : 172-188, 1940
 
52) Rose HM, Ragan C, Pearce E, et al : Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid rthritis. Proc Soc Exp Biol Med 68 : 1-6, 1948
 
53) Hargraves MM Richmond H, Morton R : Presentation of two bone marrow elements ; the tart cell and the LE cell. Proc Staff Meet Mayo Clin 23 : 25-28, 1948
 
54) Tan EM : The LE cell and antinuclear antibodies ; a breakthrough in diagnosis. Landmark advances in Rheumatology, ed by McCarty DJ. 44-50, 1984
 
55) Cecil RL, Nicholls EE, Stainsby WJ : Characteristics of streptococci isolated from patients with rheumatic fever and chronic infectious arthritis. Am J Pathol 6 : 619-625, 1930
 
56) Harboe M : Specificity of rheumatoid factor for genetic types of human gamma blobulin. Arthritis Rheum 6 : 427-445, 1963
 
57) Hirose SI, Osler AG : Interaction of rheumatoid factors with urea-denatured human gamma-globulin and its subunits. J Immunol 98 : 628-637, 1967
PubMed
58) 東威 : 感作血球凝集反応 (RAHAテスト) の検討.リウマチ 12 : 330-336, 1973
 
59) Johnson PM, Faulk WP : Rheumatoid factor ; its nature, specificity and production in rheumatoid arthritis. Clin Immunol Immunopathol 6 : 41 4-430, 1976
 
60) Haserick JR, Lewis LA, Bortz DW : Blood factor in acute disseminated lupus erythematosus ; Determination of gamma globulin as specific plasma fraction. Am J Med Sci 219 : 660-663, 1950
PubMed
61) Deicher HR, Holman HR, Kunkel HG : The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J Exp Med 109 : 97-114, 1959
 
62) Tan EM : Autoantibodies to nuclear antigens (ANA) : their immunobiology and medicine. Adv Immunol 33 : 167-240, 1982
PubMed
63) 沖中重雄, 西川光夫 : リウマチの病理解剖. 大高裕一, 岡林篤, 鈴江懐他編. リウマチ ; 新しい考え方と治療. 大阪, 永井書店, 99-105, 1955
 
64) Hench S : The effects of cortisone and corticotrophin, Scalpel (Brux) 106 : 1244-1245, 1953
PubMed
65) 橋本明 : リウマチ様関節炎の金療法に関する研究. リウマチ 3 : 18-62, 1961
 
66) 間得之 : シンポジウム I 関節リウマチの治療における最近の動向 (1) 薬物療法について. 第9回日本リウマチ学会総会, 1965
 
67) 斎藤輝信 : Aspirin大量療法における胃障害に関する研究 1-3 ; Aspirin大量療法における胃粘膜変化と出血傾向に関する研究. リウマチ 8 : 45-88, 1968
 
68) 斎藤輝信 : Aspirin大量療法における胃障害に関する研究 1-3 ; Aspirinによる胃粘膜出血の発生要因に関する実験的研究. リウマチ 8 : 56-75, 1968
 
69) 斎藤輝信 : Aspirin大量療法における胃障害に関する研究 1-3 ; Radio capsuleによるAspirin胃障害の臨床的研究. リウマチ 8 : 76-88, 1968
 
70) Stauffer RN : Total joint replacement : Historical perspective and future promise. Landmark advances in Rheumatology, ed by MacCarty DJ. American Rheumatism Association, 61-70, 1984
 
71) Allison N, Coonse GK : Synovectomy in chronic arthritis. Arch Surg 18 : 824-840, 1929
 
72) Muller W : Zur Frage der operativen Behandlung der Arthritis deformans und des chronischen Gelenk-rheumatismus. Arch Klin Chir 47 : 1-39, 1894
 
73) Shuller M : Pathologie und Therapie der Gelenkentzundungen. Vienna, Urban & Schwartzberg, 1884
 
74) Goldthwait JE : Knee joint surgery for non-tuberculous conditions. Trans Am Orhtoped Assoc 13 : 25, 1900
 
75) Murphy JB : Hypertrophic villous synovitis of the knee-joint in synovial capsulectomy, Surg Clin Chicago 5 : 155-164, 1916
 
76) Swett PP : Synovectomy in chronic infectious arthritis, J Bone Joint Surg Am 5 : 110-121, 1923
 
77) Ghormley RK, Cameron DM : End results of synovectOmy of the knee joint, Am J Surg 53 : 455-459, 1941
 
78) 鳥居敏雄 : 気象病の発生機序に関する研究. 清水源一郎編. リウマチ ; 新しい考え方と治療. 大阪, 永井書店, 78-91, 1955
 
79) Barton JR : On the treatment of ankylosis, by the formation of artificial joints. North Am Med Surg J 3 : 279-292, 1827
 
80) Jones R, Lovett RW : Orthopedic Surgery. New York, William Wood and Co., 1929
 
81) Murphy JB : Arthroplasty. Ann Surg 57 : 593, 1913
PubMed
82) Smith-Peterson MN : Arthroplasty of the hip ; a new method. JBJS 21 : 269, 1939
 
83) Venable CS, Stuck WG : Electrolysis controlling factor in the use of metals in treating fractures. JAMA 111 : 1349-1352, 1938
 
84) Johnston RC, Larson CB : Results of treatment of hip disorders with cup arthroplasty, J Bone Joint Surg Am 51 : 1461-1479, 1969
PubMed
85) Hey-Groves EW : Some contributions to the reconstructive surgery of the hip. Br J Surg 14 : 486-517, 1926
 
86) Bohlman HR : Replacement reconstruction of the hip. Am J Surg 84 : 268-278, 1952
PubMed
87) Flaboush EJ : A new operation for arthroplasty of the hip based on biomechanics, photoelasticity, fast-setting dental acrylic, and other considerations. Bull Hosp Joint Dis 14 : 242-277, 1953
 
88) Moore AT : Metal hip joint ; a new self-locking vitallium prosthesis. South Med J 45 : 1015-1019, 1952
PubMed
89) Thompson FR : Two and a half years' experience with a vitallium intramedullary hip prosthesis. J Bone Joint Surg Am 36-A : 489-502, 1954
 
90) Wiltse LL, Hall RH, Stenehjem JC : E×perimental studies regarding the possible use of self-curing acrylic in orthopaedic surgery. J Bone Joint Surg Am 39-A : 961-972, 1957
 
91) Charnley J : Anchorage of the femoral head prosthesis to the shaft of the femur. J Bone Joint Surg Br 42-B : 28-30, 1960
 
92) Charnley J : The reaction of bone to self-curing acrylic cement. A long term histological study in man. J Bone Joint Surg Br 52 : 340-353, 1970
 
93) Ring PA : Total replacement of the hip. Clin Orthop Relat Res 72 : 161-168, 1970
PubMed
94) McKee GK, Watson-Farrar J : Replacement of arthritic hips by the McKee-Farrar prosthesis. J Bone Joint Surg Br 48 : 245-259, 1966
PubMed
95) Coventry MB, Beckenbaugh RD, Nolan DR, et al : 2,012 total hip arthroplasties ; a study of postoperative course and early complications. J Bone Joint Surg 56 : 273-284, 1974
PubMed
96) Harris WH, McCarthy JC Jr, O'Neill DA : Femoral component loosening using contemporaly tachniques of femoral cement fixation. J Bone Joint Surg Am 64 : 1063-1067, 1982
 
97) Kelly IG : Surgical treatment of the rheumatoid hip. Ann Rheum Dis 49 (supple 2) : 858-862, 1990
 
98) Severt R, Wood R, Cracchiolo A 3rd, et a1 : Long-term follow-up of cemented total hip arthroplasty in rheumatoid arthritis, Clin Orthop Relat Res 265 : 137-145, 1991
 
99) Torisu T, Utsunomiya K, Masumi S, Maekawa M : Bipolar hip arthroplasty in rheumatoid arthritis. Clin Orthop Relat Res 244 : 188-1 97, 1989
 
100) MacIntosh DL : Hemiarthroplasty of the knee using aspace occupying prosthesis for painful varus and valgus defOrmities. J Bone Joint Surg 40A, 1431, 1958
 
101) Jones WN, Aufranc OE, Kermond WJ : Mold arthroplasty of the knee. J Bone Joint Surg 49-A : 1022, 1967
 
102) Robinson RP : The early innovators of today's resurfacing condylar knees. J Arthroplasty 20 (1 Suppl 1) : 2-26, 2005
 
103) Kodama T, Yamamoto S : Total knee prosthesis without hinge. Total Knee Replacement. Institute of Mechanical Engineering, London, 1975
 
104) Yamamoto S : Total knee replacement with the Kodama-Yamamoto knee prosthesis. Clin Orthop Relat Res 145 : 60-67, 1979
PubMed
105) Yamamoto S, Nakata S, Kondoh Y : A follow up study of an uncemented knee replacement. The results of 312 knees using the Kodama-Yamamoto prosthesis. J Bone Joint Surg Br 71 : 505-508, 1989
PubMed
106) Yamamoto S, Nakata S, Takubo N : Survivorship Analysis of the Kodama-Yamamoto knee prosthesis. Jpn J Rheum Joint Surg 16 : 193-200, 1997
 
107) Rodriguez JA, Saddler S, Edelman S, et ai : Long-term results of total knee arthroplasty in class 3 and 4 rheumatoid arthritis. J Arthroplasty 11 : 141-145, 1996
 
108) Schroder FIM, Aaen K, Hansen EB, et al : Cementless total knee arthroplasty in rheumatoid arthritis, A report on 51 AGC knees followed for 54 months. J Arthroplasty 11 : 18-23, 1996
 
109) Morrey BF, Bryan RS, Dobyns JH, et al : Total elbow arthroplasty, A five-year experience at the Mayo Clinic. J Bone Joint Surg Am 63 : 1050-1063, 1981
 
110) Dee R : Total replacement arthroplasty of the elbow for rheumatoid arthritis, J Bone Joint Surg 54B : 88-95, 1972
 
111) Kudo H, Iwano K, Watanabe S : Total replacement of the rheumatoid elbow with a hingeless prosthesis, J Bone joint Surg 62 : 277-285, 1980
PubMed
112) Kudo H, Iwano K : Total elbow arthroplasty with a non-constrained surface-replacement prosthesis in patients who have rheumatoid arthritis. A long-term follow-up study. J Bone Joint Surg Am 72 : 355-362, 1990
PubMed
113) Kudo H Iwano K, Nishino J : Cementless or hybrid total elbow arthroplasty with titanium-alloy implants. A study of interim clinical results and specific complications. J Arthroplasty 9 : 269-278, 1994
PubMed
114) Kudo H, Iwano K, Nishino J : Total elbow arthroplasty with use of a nonconstrained humeral component inserted without cement in patients who have rheumatoid arthritis. J Bone Joint Surg Am 81 : 1268-1280, 1999
PubMed
115) Mori T, Kudo H, Iwano K, Juji T : Kudo type-5 total elbow arthroplasty in mutilating rheumatoid arthritis ; a 5-to 11-year follow-up. J Bone Joint Surg Br 88 : 920-924, 2006
PubMed
116) Inoue H, Yokoyama Y, Tanabe G : Almina ceramic elbow arthroplasty. Rheumatology 15 : 78-87, 1991
 
117) Inoue H, Yokoyama Y, Sumii H : Elbow arthroplasty with ceramic prosthesis. Techniques in Orthopaedics 6 : 27-32, 1991
 
118) Little CP, Graham AJ, Karatzas G, et al : Outcomes of total elbow arthroplasty for rheumatoid arthritis : comparative study of three implants. J Bone Joint Surg Am 87 : 2439-2448, 2005
PubMed
119) Souter WA : Surgery of the rheumatoid elbow. Ann Rheum Dis 49 : 871-882, 1990
PubMed
120) Morrey BF, Adams RA : Semiconstrained arthroplasty for the treatment of rheumatoid arthritis of the elbow. J Bone Joint Surg Am 74 : 479-490, 1992
PubMed
121) Mori M, Ogawa R : Anterior capsulectomy in the treatment of rheumatoid arthritis of the knee joint. Arthritis Rheum 6 : 130-137, 1963
 
122) Arthritis and Rheumatism Council : Controlled trial of synovectomy of knee and metacarpophalangeal joints in rheumatoid arthritis. Ann Rheum Dis 35 : 437-442, 1976
 
123) Arthritis Foundation Committee on Evaluation of Synovectomy. Multicenter evaluation of synovectomy in the treatment of rheumatoid arthritis. Arthritis Rheum 20 : 765-771, 1977
 
124) 森益太 : 慢性関節炎における滑液膜切除術の吟味. 日整会誌 28 : 368-370, 1954
 
125) 森益太 : 日本整形外科学会総会記録 1956
 
126) 森益太 : 関節リウマチの治療における最近の動向. 第9回日本リウマチ学会総会抄録集, 1965
 
127) 柏木大治 : 第12回日本リウマチ学会抄録集, 1968
 
128) 森益太 : 第16回日本リウマチ学会抄録集, 1972
 
129) 第18回日本リウマチ学会抄録集, 1974
 
130) Ishikawa H, Ohno O, Hirohata K : Long-term effects of synovectomy in rheumatoid patients. J Bone Joint Surg [Am] 68-A : 198-205, 1986
 
131) Matsui N, Taneda Y, Ohta H, Itoh T, Tsuboguchi S : Arthroscopic versus open synovectomy in the rheumatoid knee. Int Orthop 13 : 17-20, 1989
PubMed
132) 龍順之助, 斉藤修, 本田隆仁, 島倉義成, 佐野精司 : リウマチ膝に対する鏡視下および外科的滑膜切除術の比較. リウマチ 35 : 880-888, 1995
 
133) 吉野槙一 : 関節リウマチに対する根治的多関節滑膜切除術 ; 短期術後成績について. リウマチ 34 : 908-913, 1994
 
134) 津下健哉 : 日本リウマチ学会, 1968
 
135) 中村安成, 津下健哉 : 日本リウマチ学会抄録集, 1972
 
136) 津下健哉 : Editorial関節リウマチと手の外科 ; 滑膜切除を中心として. リウマチ 27 : 269-271, 1987
 
137) 津下健哉 : リウマチ手の変形と治療. リウマチ 3 : 1317-1325, 1990
 
138) Flatt AE : Care of the arthritic hand. St. Louis, CV Mosby, 1963
 
139) Swanson AB : Si｜icone rubber implants for replacement of arthritis or destroyed joints in the hand. Surg Clin North Am 48 : 1113-1127, 1968
PubMed
140) 小林郁雄 : 慢性関節リウマチにおける手関節形成術の問題点. リウマチ外科 2 : 61-66, 1974
 
141) 立沢喜和 : 関節リウマチの手関節. リウマチ 22 : 75-87, 1982
 
142) 内田奎佑 : 手術摘出滑液膜標本による膝関節リウマチの病理組織学的研究. リウマチ 9 : 187-245, 1969
 
143) Lever JD, Ford HER : Histological, histochemical and electron microscopic observaions on synovial membrane. Anat Rec 132 : 525-539, 1958
 
144) Barland P, Novikoff AB, Hamerman D : Electron microscopy of the human synovial membrane. J Cell Biol 14 : 207-220, 1962
PubMed
145) Hirohata K, Kobayashi I : Fine structures of synovial tissues in rheumatoid arthritis, Kobe J Med Sci 10 : 195-225, 1964
PubMed
146) Ugai K, Ishikawa H, Hirohata K, Shirane H : Interaction of polymorphOnuclear leukocytes with immune complexes trapped in rheumatoid articular cartilage. Arthritis Rheum 26 : 1434-1441, 1983
PubMed
147) Kurosaka M, Ziff M : Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med 158 : 1191-1210, 1983
PubMed
148) Iguchi T, Kurosaka M Ziff M : Electron microscopic study of HLA-DR and monocyte/macrophage staining cells in the rheumatoid synovial membrane. Arthritis Rheum 29 : 600-613, 1986
PubMed
149) Iguchi T, Ziff M : Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 77 : 355-361, 1986
PubMed
150) Ishikawa H, Hirohata K : An immunoelectron-microscopic study of the immunoglobulin-synthesizing cells of the rheumatopid synovial membrane. Clin Orthop Relat Res 185 : 280-289, 1984
PubMed
151) Iguchi T, Matsubara T, Kawai K, Hirohata K : Clinical and histologic observations of monoarthritis. Anticipation of its progression to rheumatoid arthritis. Clin Orthop Relat Res 250 : 241-249, 1990
PubMed
152) 土井田稔, 水野耕作 : 慢性関節リウマチの病理組織像 : NEW MOOK整外 ; 1 慢性関節リウマチ (第1版). 越智隆弘, 菊地臣一編. 東京, 金原出版, 97-106, 1997
 
153) Arai M : Catalase activity of synovial fluid in joint diseases. Tohoku J Exp Med 91 : 35-40, 1967
PubMed
154) 阿部正隆 : 慢性関節リウマチ患者の関節液検査成績とその意義, リウマチ 11 : 369-373, 1971
 
155) Fassbender HG : Pathologie rheumatischer Erkrankungen. Springer-Verlag, Berlin-Heidelberg, 1975
 
156) Klareskog L, Holmdahl R, Goldschimidt T, et al : Immunoregulation in arthritis. A review of synovial immune reactions in RA and in some experimental animal models for arthritis. Scand J Rheumatol 64 (suppl) : 7-15, 1987
 
157) Aoki S, Imamura S, Aoki M, McCabe WR : "Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med 281 : 1375-1382, 1969
PubMed
158) Aoki S, Ikuta K, Aoyama G : Induction of chronic polyarthritis in rabbit. Nature 237 : 168-169, 1972
PubMed
159) Aoki S, Ikuta K, Nonogaki T, Ito Y : Induction of chronic polyarthritis in rabbits by hyperimmunization with Escherichia coli. I. Pathologic and serologic features in two breeds of rabbits. Arthritis Rheum 28 : 522-528, 1985
PubMed
160) Aoki S, Yosikawa K, Yokoyama T, Nonogaki T, Iwasaki S, Mitsui T, Niwa S : Role of enteric bacteria in the pathogenesis of rheumatoid arthritis ; evidence for antibodies to enterobacterial common antigens in rheumatoid sera and synovial fluids. Ann Rheum Dis 55 : 363-369, 1996
 
161) Aoki S, Mitsui T : Histological features of rheumatoid arthritis patients having antibodies to enterobacterial common antigens ; correlation of antibody levels with semiquantitative histologic scores and laboratory markers. Clin Exp Rheumatol 23 : 13-18, 2005
PubMed
162) 青木重久 : 関節リウマチの原因療法を目指して. Mod Physician 32 : 378-379, 2012
 
163) Sutton RN, Emond RT, Thomas DB, et al : The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol 17 : 427-436, 1974
PubMed
164) Slaughter L, Carson DA, Jensen FC, et al : In vitro effect of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 148 : 1429-1434, 1978
 
165) Alspaugh MA, Jensen FC, Rabin H, et al : Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 147 : 1018-1027, 1978
PubMed
166) Billings PB, Hoch SO, White PJ, et al : Antibodies to the Epstein-Barr virus nuclear antigen and rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci USA 80 : 7104-7108, 1983
 
167) Depper JM, Bluestein HG, Zvaifler NJ : Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect, J Immunol 127 : 1899-1902, 1981
 
168) Kahan A, Kahan A, Amor B, et al : Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis. Arthritis Rheum 28 : 961-970, 1985
PubMed
169) Whittingham S, McNeilage J, Mackay IR : Primary Sjogren's syndrome after infectious mononucleosis. Ann Intern Med 102 : 490-493, 1985
 
170) Fox R, Sportsman R, Rhodes G, et al : Rheumatoid arthritis synovial membrane contains a 62,000-molecuiar-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J Clin Invest 77 : 1539-1547, 1986
 
171) Fox Rit Chilton T, Rhodes G, et al : Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes. J Immunol 137 : 498-501, 1986
 
172) Takei M, Mitamura K, Fujiwara S, Horie T, Ryu J, Osaka S, Yoshino S, Sawada S : Detection of Epstein-Barr virus-encoded small RNA-1 and latent membrane protein 1 in synovia川ining cells from rheumatoid arthritis patients, Int Immunol 9 : 739-743, 1997
 
173) Reid DM, Reid TM, Brown T, et al : Human parvovirus-associated arthritis ; a clinical and laboratory description. Lancet 1 : 422-425, 1985
 
174) Sasaki T, Takahashi Y, Yoshinaga K, Sugamura K, Shiraishi H : An association beween human parvovirus B-19 infection and autoantibody production, J Rheumatol 16 : 708-709, 1989
 
175) Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K, Abe K : Persistent infection of human parvovirus B 19 in a normal subject. Lancet 346 : 851, 1995
 
176) Murai C, Munakata Y, Takahashi Y, Ishii T, Shibata S, Funato T, Nakamura M Sugamura K, Sasaki T : Rheumatoid arthrits after human parvovirus B19 infection. Ann Rheum Dis 58 : 130-132, 1999
 
177) Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, Saitoh T, Sawai T, Sugamura K, Sasaki T : Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci 95 : 8227-8232, 1998
PubMed
178) Poiesz BJ, Ruscetti FW, Gazdar AF, et al : Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77 : 7415-7419, 1980
PubMed
179) Yoshida M, Miyoshi L Hinuma Y : Isolation and characterization of retrovirus from cell lines of adult T-cell leukemia and its implication in the disease, Proc Natl Acad Sci USA 79 : 2031-2035, 1982
 
180) Nishioka K, Maruyama l, Sato K, Kitajima I, Nakajima Y, Osame M : Chronic inflammatory arthropathy associated with HTLV-1. Lancet 1 : 441, 1989
 
181) Kitajima l, Yamamoto K, Sato K, Nakajima Y, Nakajima T, Maruyama L Osame M, Nishioka K : Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest 88 : 1315-1322, 1991
 
182) Nakajima T, AOno H, 卜iasunuma T, Yamamoto K, Maruyama I, Nosaka T, Hatanaka M, Nishioka K : Overgrowth of human synovial cells driven by the human T cell leukemia virus type I taxgene. J Clin Invest 92 : 186-193, 1993
 
183) lwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima l, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, Sekiguchi T : Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 253 : 1026-1028, 1991
 
184) Hasunuma T, Nakajima T, Aono H, Sato K, Matsubara T, Yamamoto K, Nishioka K : Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-1. Clin Immunol Immunopathol 72 : 90-97, 1994
PubMed
185) Nishioka K, Sumida T, Hasunuma T : Human T lymphotropic virus type I in arthropathy and autoimmune disorders. Arthritis Rheum 39 : 1410-1418, 1996
PubMed
186) Ochi T, Yoshikawa H, Toyosaki-Maeda T, Lipsky PE : Mesenchymal stromal cells. Nurse-like cells reside in the synovial tissue and bone marrow in rheumatoid arthritis. Arthritis Res Ther 9 : 201, 2007
PubMed
187) Fujimoto M, Ochi T, Owaki H, Wakitani S, Suzuki R, Takai M, Ono K : Elevated activity of interleukin-1, -2, and -3 in the bone marrow of collagen-induced arthritis rats. Biomed Res 9 : 401-407, 1988
 
188) Hayashida K, Ochi T, Fujimoto M, Owaki H, Shimaoka Y, Ono K, Matsumoto K : Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Interieukin-1 and interleukin-6 activity and abnormal myelopoiesis. Arthritis Rheum 35 : 241-245, 1992
 
189) Ochi T, Hakomori S, Adachi M, Owaki H, Okamura M, Ono Y, Yamasaki K, Fujimoto M, Wakitani S, Ono K : The presence of a myeloid cell population showing strong reactivity with monoclonal antibody directed to difucosyl type 2 chain in epiphyseal bone marrow adjacent to joints affected with rheumatoid arthritis (RA) and its absence in the corresponding normal and non-RA bone marrow. J Rheumatol 15 : 1609-1615, 1988
PubMed
190) Owaki H, Ochi T, Yamasaki K, Yukawa K, Wakitani S, Okamura M Ono K : Elevated activity of myeloid growth factor in bone marrow adjacent to joints affected by rheumatoid arthritis. J Rheumatol 16 : 572-577, 1989
PubMed
191) Tomita T, Kashiwagi N, Shimaoka Y, Ikawa T, Tanabe M, Nakagawa S, Kawamura S, Denno K, Owaki H, Ochi T : Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J Rheumatol 21 : 1608-1614, 1994
PubMed
192) Nakagawa S, Toritsuka Y, Wakitani S, Denno K, Tomita T, Owaki H, Kimura T, Shino K, Ochi T : Bone marrow stromal cells contribute to synovial cell proliferation in rats with collagen induced arthritis. J Rheumatol 23 : 2098-2103, 1996
PubMed
193) Shimaoka Y, Attrep JF, Hirano T, lshihara K, Suzuki R, Toyosaki T, Ochi T, Lipsky PE : Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest 102 : 606-618, 1998
 
194) Takeuchi E, Tomita T, Toyosaki-Maeda T, Kaneko M, Takano H, Hashimoto H, Sugamoto K, Suzuki R, Ochi T : Establishment and characterization of nurse celHike stromal cell lines from synovial tissues of patients with rheumatoid arthritis. Arthritis Rheum 42 : 221 -228, 1999
 
195) Tomita T, Takeuchi E, Toyosaki-Maeda T, Oku H, Kaneko M, Takano H, Sugamoto K, Ohzono K, Suzuki R, Ochi T : Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis ; indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis. Rheumatology 38 : 854-863, 1999
PubMed
196) Wekerle H, Ketelsen UP : Thymic nurse cells-Ia bearing epithelium involved in T-lymphocyte differentiation? Nature 283 : 402-404, 1980
 
197) Wekerle H, Ketelsen UP, Ernst M : Thymic nurse cells. Lymphoepithelial cell comple×es in murine thymuses ; morphological and serological characterization. J Exp Med 151 : 925-944, 1980
 
198) Hayashida K, Shimaoka Y, Ochi T, Lipsky PE : Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanisms. J Immunol 164 : 1110-1116, 2000
 
199) Toyosaki-Maeda T, Takano H, Tomita T, Tsuruta Y, Maeda-Tanimura M, Shimaoka Y, Takahashi T, Itoh T, Suzuki R, Ochi T : Differentiation of monocytes into multinucleated giant bone-resorbing cells ; two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res 3 : 306-310, 2001
PubMed
200) Tsuboi H, Udagawa N, Hashimoto J, Yoshikawa H, Takahashi N, Ochi T : Nurse-like cells from patients with rheumatoid arthritis supPort the survival of osteoclast Precursors via macrophage colonystimulating factor production. Arthritis Rheum 52 : 3819-3828, 2005
 
201) Burger JA, Tsukada N, Burger M, et al : Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96 : 2655-2663, 2000
PubMed
202) Tsukada N, Burger JA, Zvaifler NJ, et al : Distinctive features of "nurse-like" cells that differentiate in the context of chronic lymphocytic leukemia. Blood 99 : 1030-1037, 2002
 
203) Burger JA, Zvaifler NJ, Tsukada N, et al : Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1-and CD106 (VCAM-1) -dependent machaninsm. J Clin Oncol 107 : 305-315, 2001
 
204) Hirohata S, Miura Y, Tomita T, Yoshikawa H, Ochi T : Enhanced expression of mRNA for nuclear factor kappaB 1 (P50) in CD34+ cells of the bone marrow in rheumatoid arthritis. Arthritis Res Ther 8 : R54, 2006
PubMed
205) Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S, Tomita T, Ochi T : Induction of fibroblast-like cells from CD34 (+) progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol 70 : 413-421, 2001
PubMed
206) Lee HM, Sugino H, Aoki C, Shimaoka Y, Suzuki R, Ochi K, Ochi T, Nishimoto N : Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis. Arthritis Res Ther 13 : R89, 2011
PubMed
207) Ollier WE, MacGregor A : Genetic epidemiology of rheumatoid disease. Br Med Bull 51 : 267-285, 1995
PubMed
208) Linos A, Worthington JW, O'Fallon WM, et al : The epidemiology of rheumatoid arthritis in Rochester, Minnesota ; a study of incidence, prevalence and mortality. Am J Epidemiol 111 : 87-98, 1980
 
209) Symmons DP, Barrett EM, Bankhead CR, et al : The incidence of rheumatoid arthritis in the United Kingdom ; results from the Norfolk Arthritis Register. Br J Rheumatol 33 : 735-739, 1994
PubMed
210) Spector TD, Hart DJ, Powell RJ : Prevalence of rheumatoid arthritis and rheumatoid factor in women ; evidence for a secular decline. Ann Rheum Dis 52 : 254-257, 1993
PubMed
211) Hollingsworth JW : Delayed radiation effects in survivors of the atomic bombings. A summary of the findings of the Atomic Bomb Casualty Commission, 1947-1959. N Engl J Med 263 : 481-487, 1960
PubMed
212) Wood JW, Kato H, Johnson KG, Uda Y, et al : Rheumatoid arthritis in Hiroshima and Nagasaki, Japan. Prevalence, incidence, and clinical characteristics. Arthritis Rheum 10 : 21-31, 1967
PubMed
213) Kato H, Duff IF, Russell WJ, Uda Y, Kawamoto S, et al : Rheumatoid arthritis and gout in Hiroshima and Nagasaki, Japan. A prevalence and incidence study. J Chronic Dis 23 : 659-679, 1971
PubMed
214) Shichikawa K, Mayeda A, Komatsubara Y, Yamamoto T, Akabori O, Hongo I, Kosugi T, Miyauchi T : Rheumatic complains in urban and rural populations in Osaka. Ann Rheum Dis 25 : 25-31, 1966
 
215) 大島良雄 : シンポジウム 膠原病の臨床 ; V. 膠原病におけるリウマチの位置. 日内会誌 50 : 124-130, 1961
 
216) Shichikawa K, Takenaka Y, Maeda A, Yoshino R, Tsujimoto M Ota H, Kashiwade T, Hongo I : A longitudinal population survey of rheumatoid arthritis in a rural district in Wakayama. Ryumachi 21 (Suppl) : 35-43, 1981
 
217) Vyse TJ, Todd JA : Genetic analysis of autoimmune disease. Cell 85 : 311-318, 1996
PubMed
218) Aho K, Koskenvuo M, Tuomimen J, et al : Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13 : 899-902, 1986
 
219) Lilly F : The inheritance of susceptibility to the Gross Leukemia virus in mice. Genetics 53 : 529-539, 1966
 
220) Jersild C, Fog T, Hansen GS, et al : Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 2 : 1221-1225, 1973
PubMed
221) Stastny P : Mi×ed lymphocyte culture typing cells from patients with rheumatoid arthritis. Tissue Antigens 4 : 571-579, 1974
 
222) Stastny P : Association of the B-cell alloantigen DRw 4 with rheumatoid arthritis. N Engl J Med 298 : 869-871, 1978
 
223) Toyoda K, Saito S, Naito S, Konomi K, Yamamoto H : HLA antigens in classical and malignant rheumatoid arthritis in Japanese population. Tissue Antigens 10 : 56-59, 1977
PubMed
224) Maeda H, Juji T, Mitsui H, Sonozaki H, Okitsu K : HLA-DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis 40 : 299-302, 1981
PubMed
225) Ohta N, Nishimura YK, Tanimoto K, Horiuchi Y, Abe C, Shiokawa Y, Abe T, Katagiri M, Yoshiki T, Sasazuki T : Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 5 : 123-132, 1982
PubMed
226) Gregersen PK, Silver J, Winchester RJ : The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 : 1205-1213, 1987
PubMed
227) Roitt IM, Corbett M, Festenstein H, et al : HLA-DRW4 and prognosis in rheumatoid arthritis. Lancet 1 : 990, 1978
 
228) Dobloug JH, Forre O, Thorsby E : HLA-DRw4 and rheumatoid arthritis. Lancet 1 : 548-549, 1979
 
229) Weyand CM, McCarthy TG, Goronzy JJ : Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95 : 2120-2126, 1995
PubMed
230) Weyand CM, Hicok KC, Conn DL, et al : The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117 : 801-806, 1992
PubMed
231) Teller K, Budhai L, Zhang M, Haramati N : HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis ; the "shared epitope" hypothesis may not apply. J Rheumatol 23 : 1363-1368, 1996
 
232) Deighton CM, Walker DJ, Griffiths ID, et al : The contribution of FILA to rheumatoid arthritis. Clin Genet 36 : 178-182, 1989
 
233) Toda Y, Minamikawa Y, Akagi S, Sugano H, Mori Y, Nishimura H, Arita S, Sugino Y, Ogawa R : Rheumatoid-susceptible aileles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann Rheum Dis 53 : 587-592, 1994
PubMed
234) Wakitani S, Murata N, Toda Y, Ogawa R Kaneshige T, Nishimura Y, Ochi T : The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br J Rheumatol 36 : 630-636, 1997
PubMed
235) Nelson JL, Hansen JA, Singal D, Tsuchiya K, Sasazuki T : Disease component of rheumatoid arthritis. HLA 1991, ed by Tsuji K, Aizawa M, Sasazuki T. Oxford University Press, New York, 772-774, 1992
 
236) Wakitani S, lmoto K, Murata N, Oonishi H Ochi T, Yoneda M : An association between the natural course of shoulder joint destruction in rheumatoid arthritis and HLA-DRB1 *0405 in Japanese patients. Scand J Rheumatol 27 : 146-148, 1998
 
237) Wakitani S, Kuwata K, lmoto K, Murata N, Oonishi H, Ochi T : Knee and/or hip joint destruction in rheumatoid arthritis is associated with FILA-DRB1*0405 in Japanese patients. Clin Rheumatol 17 : 485-488, 1998
 
238) Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T : The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese ; Short Report. Scand J Rheumatol 27 : 381-382, 1998
PubMed
239) Higami K, Hakoda M, Matsuda Y, Ueda H, Kashiwazaki S : Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis. Arthritis Rheum 40 : 2241-2247, 1997
PubMed
240) Yukioka M, Wakitani S, Murata N, Toda Y, Ogawa R, Kaneshige T, Ochi T : Elderly-onset rheumatoid arthritis and its association with HLA-DRB1 alleles in Japanese. Br J Rheumatol 37 : 98-101, 1998
PubMed
241) Takeuchi F, Nabeta H, Kuwata S, Tanimoto K, Ito K : Association of DMA and DMB with RA in Japanese. Clin Exp Rheumatol 15 : 189-192, 1997
PubMed
242) Takeuchi F, Nakano K, Matsuta K, Takizawa K, Nabeta H, Kuwata S, Ito K : Polymorphism of TAP1 and TAP2 in Japanese patients with rheumatoid arthritis. Tissue Antigens 49 : 280-282, 1997
PubMed
243) Pinet V, Combe B Avinens O, et al : Polymorphism of the FILA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum 40 : 854-858, 1997
 
244) Wilson AG, de Vries N, Pociot F, et al : An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177 : 557-560, 1993
PubMed
245) Brinkman BM, Huizinga TW, Kurban SS, et al : Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis ; association with susceptibility to, or severity of, disease? Br J Rheumatol 36 : 516-521, 1997
 
246) Seki N, Kamizono S, Yamada A, Higuchi T, Matsumoto H, Niiya F, Kimura A, Tsuchiya K, Suzuki R, Date Y, Tomita T, Itoh K, Ochi T : Polymorphisms in the 5 Lflanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54 : 194-1 97, 1999
 
247) Shibue T, Tsuchiya N, Komada T, Matsushita M, Shiota M Ohashi J, Wakui M, Matsuta K, Tokunaga K : Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor H, and HLA-DRB 1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 43 : 753-757, 2000
 
248) Cornelis F, Faure S, Martinez M, et al : New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 95 : 10746-10750, 1998
PubMed
249) Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K, Tanaka Y, Shiozawa K, Imura S : Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10 : 1891-1895, 1998
PubMed
250) Yamada R, Tanaka T, Ohnishi Y, Suematsu K, Minami M, Seki T, Yukioka M, Maeda A, Murata N, Saiki O, Teshima R Kudo O, Ishikawa K, Ueyosi A, Tateishi H, Inaba M, Goto H, Nishizawa Y, Tohma S, Ochi T, Yamamoto K, Nakamura Y : Identification of 142 single nucleotide polymorphisms in 41 candidate genes for rheumatoid arthritis in the Japanese population. Hum Genet 106 : 293-297, 2000
PubMed
251) Sutton BM, McGusty E, Walz DT, et al : Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes, J Med Chem 15 : 1095-1098, 1972
PubMed
252) Walz DT, DiMartino MJ, Chakrin LW, et al : Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent ; SK & FD-30162. J Pharmacol Exp Ther 197 : 142-152, 1976
 
253) Walz DT, DiMartino MJ, Griswold DE : Comparative pharmacology and biological effects of different gold compounds. J Rheumatol Suppl 8 : 54-60, 1982
PubMed
254) Finkelstein AE, Walz DT, Batista V, et al : Auranofin. New oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis 35 : 251-257, 1976
PubMed
255) Abraham EP, Chain E, Baker W, et al : Penicillamine, acharacteristic degradation product of penicillin. Nature 151 : 107, 1943
 
256) Walshe JM : Wilson's disease ; new oral therapy. Lancet 270 : 25-26, 1956
 
257) Crawhall JC, Scowen EF, Watts RWE : Effect of penicillamine on cystinuria. Br Med J 1 : 588-590, 1963
 
258) Deutsch HF, Morton JI : Dissociation of human serum macroglobulins. Science 125 : 600-601, 1957
PubMed
259) Dresner E, Trombly P : Chemical dissociation of the rheumatoid factor in vitro and in vivo. Clin Res 8 : 16, 1960
 
260) Griffin SW, Ulloa A, Henry M, et al : In vivo effect of peniciHamin on circulating rheumatoid factor. Clin Res 8 : 87, 1960
 
261) Jaffe IA : Intra-articular dissociation of the rheumatoid factor, J Lab Clin Med 60 : 409-421, 1962
PubMed
262) Jaffe IA : Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor. Ann Rheum Dis 22 : 71-76, 1963
PubMed
263) Jaffe IA : The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum 13 : 436-443, 1970
PubMed
264) Andrews FM, Golding DN, Freeman AM, et al : Controlled trial of D-Penicillamine in severe rheumatoid arthritis. Lancet 301 : 275-280, 1973
 
265) Amor B, Mery C, de Gery A : Tiopronin (N- [2-mercaptopropionyl] glycin) in rheumatoid arthritis, Arthritis Rheum 25 : 698-703, 1982
PubMed
266) Pasero G, Pellegrini P, Ambanelli U, et al : Controlled multicenter trial of tiopronin and d-penic川amine for rheumatoid arthritis. Arthritis Rheum 25 : 923-929, 1982
 
267) Oya M, Matsumoto J, Takashina H, Watanabe T, Iwao J : Thiol compounds. II. 1) Synthesis and antihypertensive activity of mercaptoacylamino acids. Chem Pharm Bull 29 : 940-947, 1981
PubMed
268) Iso T, Yamauchi H, Hayashi M, Abe C : Pharmacological profiles of sa 96 a new antirheumatic agent effect on primary immune response and macrophage function in mice. Int J Immunotherapy 1 : 93-98, 1985
 
269) 塩川優一, 安倍千之, 蕨治言, 阿部重人, 景山孝正, 小坂志朗, 本間光夫, 秋月正史, 山縣元, 水島裕, 菅原幸子, 石上宮子, 七川歓次, 大藤眞塩孜 : 新しい抗リウマチ剤SA96の慢性関節リウマチに対する臨床的検討 ; 早期第二相臨床試験. 炎症 5 : 333-343, 1985
 
270) Svartz N : Salazopyrin, a new sulfanilamide preparation. A. therapeutic results in rheumatic Polyarthritis. B. therapeutic results in ulcerative colitis. C. toxic manifestations in treatment with sulfanilamide preparations. Acta Med Scand 110 : 577-598, 1942
 
271) Sinclair RJG, Duthie JJR : Salazopyrin in the treatment of rheumatoid arthritis. Ann Rheum Dis 8 : 226-231, 1949
 
272) McConkey B, Amos RS, Durham S, et al : Sulphasalazine in rheumatoid arthritis. Br Med J 280 : 442-444, 1980
PubMed
273) Fujiwara M, Mitsui K, Yamamoto I : Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites. Jpn J Pharmacol 54 : 121-131, 1990
PubMed
274) Ohsugi Y, Hata Sl, Tanemura M, Nakano T, Matsuno T, Takagaki Y, Nishi Y, Shindo M : N- (2-Carbo×yphenyD-4-chloroanthranilic acid disodium salt ; a novel anti-arthritic agent without anti-inflammatory and immunosuppressive activities. J Pharm Pharmacol 29 : 636-637, 1977
 
275) 大杉義征, 中野利昭, 畑俊一 : 新抗リウマチ剤, lobenzarit disodium (CCA) ; ラットアジュバント関節炎阻害作用における胸腺由来リンパ球の役割. 炎症 4 : 243-245, 1984
 
276) 森山史好 : ロベンザリットニナトリウム. ファルマシア 22 : 1265-1268, 1986
 
277) 中外製薬株式会社 : カルフェニール. 医薬ジャーナル 22 : 133-140, 1986
 
278) 藤沢広, 吉田博次, 柴田芳久, 佐藤茂, 安倍千之, 広瀬俊一, 塩川優一 : MRL/リットルマウスにおける自然発症腎炎に及ぼすMS-932の効果. 炎症 6 : 285-290, 1986
Medical*Online
279) Yoshida H, Fujisawa H, Abe C, Shibata Y, Sato S, Shiokawa Y : Effect of MS-932 (4-acetylaminophenylacetic acid) on articular lesions in MRL/l mice. Int J Immunotherapy 3 : 261-264, 1987
 
280) Bahous L Rosenthal M : Basic treatment of rheumatoid arthritis with an immunomodulating agent at two distinct dosage regimens ; a double blind clinical study. Int J Immunother 3 : 265-270, 1987
 
281) Nakagawa Y, Ogawa T, Umezu K, Shibata Y, Fujisawa H, Sato S : Suppressive effect of 4 acetylaminophenylacetic acid ms 932 on delayed type hypersensitivity in mice. Int J Immunotherapy 6 : 141-148, 1990
 
282) Nakagawa Y, Ogawa T, Umezu K, Shibata Y, Nishimura T, Sato S : Characterization of suppressor cells activated by 4 acetylaminophenylacetic acid ms 932 in delayed type hypersensitivity. Int J Immunotherapy 6 : 149-156, 1990
 
283) Mizuno K, Tsujino M, Takada M Hayashi M, Atsumi K : Studies on bredinin. 1. isolation, characterization and biological properties. J Antibiot 27 : 775-782, 1974
 
284) Sakaguchi K, Tsujino M, Yoshizawa M, Mizuno K, Hayano K : Action of bredinin on mammalian cells. Cancer Res 35 : 1643-1648, 1975
PubMed
285) Sakaguchi K, Tsujino M, Mizuno K, Hayano K, Ishida N : Effect of bredinin and its aglycone on L5178Y cells. J Antibiot 28 : 798-803, 1975
 
286) Steinberg AD : Efficacy of immunosuppressive drugs in rheumatic diseases. Arthritis Rheum 16 : 92-96, 1973
PubMed
287) Iwata H, Iwaki H, Masukawa T, Kasamatsu S, Okamoto H : Anti-arthritic activity of bredinin, an immunosuppressive agent. Experientia 33 : 502-503, 1977
PubMed
288) 佐川史郎, 石橋道男, 有馬正明, 宇佐美道之, 長船匡男, 園田孝夫, 井口正典, 秋山隆弘, 栗田孝, 辻野正俊, 水野公雄, 村瀬潤一 : 新しい免疫抑制剤の開発に関する研究 ; 第一報犬同種移植におけるBredininの免疫抑制効果. 移植 13 : 271, 1978
 
289) Leuchtenberger C, Lewisohn R, Laszlo D, et al : "Folic acid" atumor growth inhibitor. Proc Soc Exp Biol & Med 55 : 204-205, 1944
 
290) Leuchtenberger R, Leuchtenberger C, Laszlo D, et al : The influence of "folic acid" on spontaneous breast cancers in mice. Science 101 : 46, 1945
PubMed
291) Schoenbach EB, Goldin A, Goldberg B, et al : The effect of folic-acid derivatives on sarcoma 180. Cancer 2 : 57-64, 1949
 
292) Gubner R, August S, Ginsberg V : Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 221 : 176-182, 1951
PubMed
293) O'Brien WM, Van Scott EJ, Black RL, et al : Clinical trial of amethoPterin (methotrexate) in psoriatic and rheumatoid arthritis (preliminary report). Arthritis Rheum 5 : 312, 1962
 
294) Weinstein GD, Frost P : Methotrexate for psoriasis. A new therapeutic schedule. Arch Dermatol 103 : 33-38, 1971
PubMed
295) Weinblatt ME, Coblyn JS, FoxDA, et al : Efficacy of low-dose methotre×ate in rheumatoid arthritis. N Engl J Med 312 : 818-822, 1985
 
296) Williams HJ, Willkens RF, Samuelson CO Jr, et al : Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis, A controlled clinical trial. Arthritis Rheum 28 : 721-730, 1985
PubMed
297) Bartlett RR, Schleyerbach R : Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity. I. Disease modifying action on adjuvant arthritis of the rat, Int J Immunopharmacol 7 : 7-18, 1985
PubMed
298) Bartlett RR, Dimitrijevic M, Mattar T, et al : Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions 32 : 10-21, 1991
PubMed
299) Calne RY, Rolles K, White DJ, et al : Cyclosporin Ainitially as the only immunosuppressant in 34 recipients of cadaveric organs ; 32 kidneys, 2 pancreases, and 2 livers. Lancet 2 : 1033-1036, 1979
PubMed
300) Kino T, Flatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H : FK-506, a novel immunosuppressant isolated from a Streptomyces. 1. fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 40 : 1249-1255, 1987
 
301) Ochiai T, Nakajima M, Nagata M Suzuki T, Asano T, Uematsu T, Goto T, Hori S, Kenmochi T, Nakagoori T, Isono K : Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotranSplantation in the rat. Transplant Proc 19 : 1284-1286, 1987
 
302) Kino T, Hatanaka H, Miyata S, Imamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H Ochiai T : FK-506, a novel immunosupPressant isolated from a Streptomyces. II. immunosuppressive effect of FK-506 in vitro. J Antibiot 40 : 1256-1265, 1987
 
303) Starzl TE, Todo Si Fung J, et al : FK 506 for liver, kidney, and pancreas transplantation. Lancet 28 : 1000-1004, 1989
 
304) 上本伸二, 田中紘一, 山岡義生 : タクロリムス (プログラフ). 臨床麻酔 17 : 1087-1089, 1993
 
305) Magari K, Nishigaki F, Sasakawa T, Ogawa T, Miyata S, Ohkubo Y, Mutoh S, Goto T : Anti-arthritic properties of FK5060n collagen-induced arthritis in rats. Inflamm Res 52 : 524-529, 2003
PubMed
306) Magari K, Miyata S, Nishigaki F, Ohkubo Y, Mutoh S, Goto T : Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis. J Rheumatol 30 : 2193-2200, 2003
PubMed

書評

最近チェックした商品履歴

Loading...